Abstract
Selectivity through an asymmetric pathway in the degradation of non-steroidal anti-inflammatory drugs (NSAIDs) using mixed-ligand cobalt(II) complexes: experimental and theoretical insights
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
